GelStat Corp. (OTCMKTS:GSAC) Short Interest Up ∞ in May

GelStat Corp. (OTCMKTS:GSAC) saw a large growth in short interest during the month of May. As of May 29th, there was short interest totaling 100,000 shares, a growth of ∞ from the May 14th total of 0 shares. Approximately 0.0% of the company’s stock are short sold. Based on an average daily volume of 7,458,359 shares, the short-interest ratio is currently 0.0 days.

GelStat Price Performance

Shares of GSAC remained flat at $0.00 during midday trading on Friday. 3,749 shares of the stock traded hands, compared to its average volume of 1,679,688. GelStat has a one year low of $0.00 and a one year high of $0.00.

About GelStat

GelStat Corporation, a consumer health care company, engages in the research, development, and marketing of over-the-counter and other non-prescription consumer health care products. Its products include GelStat Migraine, a patented solution used for pain relief from migraine headaches; Chews 2 Lose, an appetite suppressant gum for diet aide; All Natural Speed, an energy supplement product; and GelStat Sleep, a product for relief from sleep disorders and its associated symptoms. The company sells its products to retailers, wholesalers, specialty distributors, and catalog merchandisers both directly and through external sales brokers.